Table 3.
Univariate | Multivariate | |||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Cardiovascular mortality | ||||
Baseline normal LVEF | 1.00 | – | 1.00 | – |
Recovered LVEF | 1.10 (0.39–3.08) | 0.863 | 1.95 (0.52–7.34) | 0.325 |
Persistently Reduced LVEF | 3.89 (1.93–7.85) | < 0.001 | 7.49 (1.94–28.87) | 0.003 |
HF rehospitalization | ||||
Baseline normal LVEF | 1.00 | – | 1.00 | – |
Recovered LVEF | 1.62 (0.80–3.30) | 0.180 | 0.79 (0.34–1.86) | 0.793 |
Persistently Reduced LVEF | 9.66 (5.97–15.64) | < 0.001 | 3.54 (1.56–8.06) | 0.003 |
Baseline normal LVEF was treated as reference. Multivariate adjusted for age, sex, hypertension, diabetes, chronic kidney disease, prior PCI, prior stroke, smoking, heart rate, SBP, Killip class II–IV, out-of-hospital cardiac arrest, peak troponin T, initial creatinine, multivessel disease, usage of IABP, TIMI flow 0–1 before PCI, baseline LVEF, ACEIs/ARBs at discharge, and β-blockers at discharge
HR hazards ratio, 95% CI 95% confidence interval, LVEF Left ventricular ejection fraction, HF heart failure, PCI Percutaneous coronary intervention, SBP Systolic blood pressure, IABP Intra-aortic balloon pump, TIMI Thrombolysis in Myocardial Infarction, ACEIs Angiotensin-converting enzyme inhibitors, ARBs Angiotensin II receptor blockers